104
report
State Technology and Science Index 2014
Massachusetts is first – once again – in the Milken Institute’s State Technology and Science Index
2014.
+ Read More
report
Advancing Models of Patient Engagement: Patient Organizations as Research and Data Partners
FasterCures, alongside other patient-focused advocacy organizations, has long worked with stakehold
ers such as product developers and regulators to define and implement the “how to” of patient
+ Read More
report
Cornerstones of Collaboration: Foundation-Led Partnerships to Accelerate R&D
Multi-stakeholder collaboration isn’t just the participation trophy of biomedical research and deve
lopment (R&D), a nice way to make sure everyone feels included.
+ Read More
report
One Mind's 2014 Annual Summit White Paper
At One Mind, we are dedicated to fostering fundamental changes that will radically accelerate the d
evelopment and implementation of improved diagnostics, treatments, and cures for diseases and injuries of the brain – all while eliminating the stigma and
+ Read More
report
The Bayh-Dole Act: Frequently Asked Questions
This FAQ of the Bayh-Dole Act of 1980 is part of our TRAIN program's Foundation
University Partnerships Toolkit.
+ Read More
report
Key Research Agreement Terms and Definitions
This Key Research Agreement Terms and Definitions is part of our TRAIN program's Foundation Company
Partnership Toolkit.
+ Read More
report
Unlocking Intellectual Property: Principles for Responsible Negotiation
FasterCures convened a small Intellectual Property (IP) expert panel in July 2012 to develop a
set of guiding principles and points to consider that can serve as a useful tool for all parties
+ Read More
report
Everything You Ever Wanted To Know About Venture Philanthropy Transactions But Were Afraid To Ask
Since 1989, Schaner & Lubitz, PLLC has closed many transactions for disease foundation cli
ents in the field that has come to be known as Venture Philanthropy.
+ Read More
report
Everything You Ever Wanted to Know About Royalties and Their Monetization But Were Afraid to Ask
Each Venture Philanthropy transaction involves numerous complicated issues: governance, intellectua
l property ownership and licensing, termination, indemnification, and publication, among others, but the issue that encompasses the most negotiating time
+ Read More
report
Consortia-pedia Framework Report
FasterCures initiated the Consortia-pedia project to better understand the breadth and scope of app
roaches that a wide range of consortia have adopted to bring together nontraditional partners with a shared R&D goa
+ Read More
report
IMI Socio-economic Impact Assessment Expert Group
This Innovative Medicines Initiative (IMI) report demonstrates how the first projects launched by I
MI made concrete improvements to pharmaceutical research and development (R&D); leveraging funding; creating new knowledge and tools; and making Europ
+ Read More
report
Fostering Collaborative Research For Rare Genetic Disease: The Example of Niemann-Pick Type C Disease
Rare disease represents one of the most significant issues facing the medical community and health
care providers worldwide, yet the majority of these disorders never emerge from their obscurity, drawing little attention from the medical community or th
+ Read More